|
2020
|
Invention
|
Compound for treating cystic fibrosis. Provided herein is a compound represented by Formula I: (I... |
|
2016
|
Invention
|
Ethylene glycol ether of buprenorphine.
A novel ethylene glycol ether of buprenorphine for oral ... |
|
|
Invention
|
Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked throu... |
|
|
Invention
|
Use of buprenorphine dimer in the treatment of peripheral neuropathic pain. The present invention... |
|
|
Invention
|
Ethylene glycol ether of buprenorphine. A novel ethylene glycol ether of buprenorphine for oral a... |
|
|
Invention
|
Pharmaceutically active dimers linked through phenolic hydroxyl groups.
Pharmaceutically active ... |
|
2015
|
Invention
|
Pharmaceutically active dimers linked through phenolic hydroxyl groups. Pharmaceutically active h... |
|
|
Invention
|
Buprenorphine dimer and its use in treatment of gastrointestinal disorders. The present invention... |
